The company’s Ziprasidone Hydrochloride Capsules in 20mg, 40mg, 60mg and 80mg strengths are available in 60 count bottle size.
The United States Food & Drug Administration (USFDA) approved Dr Reddy’s ANDA for Ziprasidone Hydrochloride Capsules.
The Geodon brand had US sales of approximately $1.34bn for the recent twelve months ending December 2011 according to IMS Health.
Dr Reddy’s offers a portfolio of products and services including APls, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.